Der bør gives den samme dosis i alle cyklusser, forudsat at der ikke observeres grad 3- 4- toksicitet, og forudsat at patienten opfylder kriterierne for genbehandling.
The same dose should be given for all cycles provided that no grade 3-4 toxicities are seen and that the patient fulfils the re-treatment criteria.